Cumulative ovulation and pregnancy rates according to recombinant human follicle stimulating hormone (r-hFSH) dosing: Comparison of a new formulation.

Slides:



Advertisements
Similar presentations
The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 
Advertisements

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Demián Glujovsky, M.D., M.Sc., Cynthia Farquhar, M.D., M.P.H. 
Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss.
Comparison of Sperm Motility Measurement Using SQA-V Automated Sperm Analyzer and Conventional Manual Methods  R.K. Sharma, T.M. Said, A. Agarwal  Fertility.
Stimulation of spermatogenesis with recombinant human follicle-stimulating hormone (follitropin alfa; GONAL-f®): long-term treatment in azoospermic men.
Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M
Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles  Angela R. Baerwald, Ph.D.,
Cem Atabekoglu, M. D. , Murat Sonmezer, M. D. , Sinan Özkavukcu, M. D
Medical treatment of ectopic pregnancy: a committee opinion
The relative contribution of assisted reproductive technologies and ovulation induction to multiple births in the United States 5 years after the Society.
Modified natural cycle in in vitro fertilization
Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D
D.H. Williams, S.A. Land, M. Han, P.D. Sutton, R.E. Brannigan 
The role of steroid hormone supplementation in non–assisted reproductive technology treatments for unexplained infertility  Alexander M. Quaas, M.D.,
Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss.
A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data 
Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.
Deleterious effect of tobacco on IVF outcome and ovarian reserve as reflected by serum anti mullerian hormone (AMH)  P. Barriere, T. Freour, D. Masson,
Chao-Chin Hsu, M. D. , Ph. D. , Hsin-Chih Kuo, Ph. D
A prospective randomized clinical trial of differing starter doses of recombinant follicle- stimulating hormone (follitropin-β) for first time in vitro.
Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection.
Volume 130, Issue 6, (September 2007)
Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study  Ahmet Erdem, M.D., Mehmet Erdem,
Anastrozole vs. clomiphene citrate in infertile women with ovulatory dysfunction: a phase II, randomized, dose-finding study  Donald Tredway, M.D., Ph.D.,
Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial  Robert Boostanfar, M.D.,
Improved implantation and pregnancy rates in donor recipients using transdermal hormone replacement therapy  A. Criniti, G. Chow, L. Craig, A. Khabani,
Recombinant Follicle-Stimulating Hormone (Follitropin Beta, Puregon) Yields Higher Pregnancy Rates in In Vitro Fertilization than Urinary Gonadotropins 
Clinical Assessment of Recombinant Human Follicle-Stimulating Hormone in Stimulating Ovarian Follicular Development Before In Vitro Fertilization fn1 
A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone 
Recombinant FSH versus highly purified FSH in intrauterine insemination: systematic review and metaanalysis  Roberto Matorras, M.D., Ph.D., Carmen Osuna,
A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin.
The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 
Tomer Singer, M. D. , David H. Barad, M. D. , M. S
From partner's desk to iPad
Fertility and Sterility
Cervical mucus status can be accurately estimated by transvaginal ultrasound during fertility evaluation  Igal Wolman, M.D., Tamar Birenbaum Gal, M.D.,
Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility  C.M. Howles, V. Alam, D. Tredway, R. Homburg,
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study  Carlo.
Tania Luisa Stevenson, M.B.Ch.B., Hany Lashen, F.R.C.O.G. 
Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis 
A. Criniti, G. Chow, A. Khabani, L. Scott, N.A. Klein 
Prospective cohort study of three- versus two-dimensional ultrasound for prediction of oocyte maturity  Doron Shmorgun, M.D., Edward Hughes, M.D., Patrick.
Comparison of basal follicle-stimulating hormone versus the clomiphene citrate challenge test for ovarian reserve screening  Tarun Jain, M.D., Michael.
A retrospective study on the use of dose-dependent letrozole to decrease cancer recurrence and adverse events in patients undergoing ovarian stimulation 
P-425 Fertility and Sterility Volume 86, Issue 3, (September 2006)
A double-blind clinical trial comparing a fixed daily dose of 150 and 250 IU of recombinant follicle-stimulating hormone in women undergoing in vitro.
Effectiveness of highly purified human menopausal gonadotropin vs
Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D
Stephanie A. Beall, M.D., Ph.D., Alan DeCherney, M.D. 
Efficacy of luteinizing hormone activity in patients undergoing in vitro fertilization and treated only with low-dose recombinant choriogonadotropin alfa.
L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing 
The Routine use of Follitropin Alfa (FbM) Pre-Filled Pen for Follicular Development for IVF. A Large Multinational Observational Study in Northern Europe 
P. Callum, L. Isley  Fertility and Sterility 
Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome  Madelon van Wely, Ph.D.,
Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.
Increased total and phosphorylated glycogen synthase kinase-3 (GSK-3) in the adipocytes of patients with the polycystic ovary syndrome (PCOS)  W.Y. Chang,
Fertility and Sterility
A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human.
Fertility and Sterility
Serum anti-Mullerian hormone dynamics during stimulated cycles by aromatase inhibitor anastrozole and clomiphene citrate in women with infertility  H.-H.
Comparison of the Ovulation Induction and Hormone Profile Between Anastrozole and Clomiphene Citrate in Women With Infertility  H. Wu, P. Chen, N.M. Wang,
Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function  David H. Barad, M.D., M.S., Andrea Weghofer,
In vitro sildenafil citrate use as a sperm motility stimulant
Fertility and Sterility
Performance of basal follicle-stimulating hormone and patient's age in the prediction of poor ovarian response and IVF outcome of women who developed.
Volume 134, Issue 6, (September 2008)
A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for.
Is chromosome testing of the second miscarriage cost saving
Presentation transcript:

Cumulative ovulation and pregnancy rates according to recombinant human follicle stimulating hormone (r-hFSH) dosing: Comparison of a new formulation of follitropin alfa in vials versus the standard formulation of follitropin alfa in ampules  T. Yeko, S.R. Pasqualini, V. Alam, D. Tredway  Fertility and Sterility  Volume 82, (September 2004) DOI: 10.1016/j.fertnstert.2004.07.302 Copyright © 2004 Terms and Conditions

Fertility and Sterility 2004 82, DOI: (10.1016/j.fertnstert.2004.07.302) Copyright © 2004 Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.